Citi analyst Patrick B. Donnelly has reiterated a 'Buy' rating for Thermo Fisher Scientific and increased its price target from $685 to $800. This reflects an updated positive outlook on the company's performance, suggesting potential upside for investors.
Citi analyst Patrick B. Donnelly reaffirmed a 'Buy' rating for Thermo Fisher Scientific (TMO) and raised the price target from $685 to $800. This indicates a strengthened positive view on TMO's future performance and market position. For traders, this could signal short-term positive momentum as the market reacts to the increased price target, potentially leading to an upward revision in investor sentiment. Long-term, it reinforces the bullish case for TMO, suggesting continued growth and strong fundamentals, though actual stock performance will depend on broader market conditions and company execution.